Selkova 2005a.
Methods | Randomised, placebo‐controlled trial of Oscillococcinum® in the prevention of influenza‐like illness | |
Participants | 100 professional staff (average age, 50 years approximately) in outpatient health clinic, Moscow, Russia; those with influenza‐like symptoms in previous 2 days or have family contact/s displaying influenza‐like symptoms | |
Interventions | Oscillococcinum®, prophylactically, once per week for 4 weeks | |
Outcomes | Number of participants who fell ill with influenza symptoms | |
Notes | Methodological details for each study are scantily described, but the tabulations of key results for each are clearly presented Research setting: outpatient health clinic, Moscow, Russia |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | No information on actual randomisation method |
Allocation concealment (selection bias) | Unclear risk | No description of allocation procedure |
Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | No description of blinding procedure |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | No description of blinding procedure |
Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Insufficient information provided |
Selective reporting (reporting bias) | Unclear risk | Insufficient information provided |
Other bias | Unclear risk | Insufficient information provided |